1. Short title This Act may be cited as the Comprehensive Addiction Reform, Education, and Safety Act of 2018 or the CARES Act . 2. Opioid advertising and consumer safety (a) Requiring FDA review of television advertisements for controlled substances Section 503C of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353c ) is amended— (1) in subsection (a), by striking The Secretary and inserting Subject to subsection (f), the Secretary ; (2) in subsection (c), by inserting or (f) after subsection (e) ; (3) by redesignating subsection (f) as subsection (g); and (4) by inserting after subsection (e) the following: (f) Advertisements for controlled substances (1) In general In the case of a television advertisement for a controlled substance (as defined in section 102 of the Controlled Substances Act)— (A) the Secretary shall require the submission of such advertisement under subsection (a); and (B) the sponsor of such advertisement may not disseminate the advertisement until the Secretary has conducted the review under this section. (2) Authorization of appropriations There is authorized to be appropriated $5,000,000 for the period of fiscal years 2019 through 2023 to increase the proficiency and speed of the Secretary in conducting and reviewing television advertisements for controlled substances (as so defined) under this section. . (b) Enforcement Section 301 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331 ) is amended by adding at the end the following: (eee) The failure to comply with the requirements under section 503C(f). . (c) Rule of construction No amendment made by this section shall preclude the enforcement, under any relevant civil or other enforcement authority, of a State consumer protection statute. 3. Increasing civil and criminal penalties Section 402(c) of the Controlled Substances Act ( 21 U.S.C. 842(c) ) is amended— (1) in paragraph (1)(B), by striking shall not exceed $10,000. and inserting the following: shall not exceed— (i) except as provided in clause (ii), $10,000